Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.

RA PHARMACEUTICALS
RARX
RARX (RA PHARMACEUTICALS) is held by 1 institutional investors as of Q2 2020. Top institutional shareholders: Daiwa Securities Group Inc. ($32,000).
No verdict yet — fewer than 2 funds hold RARX.
Top Holders
Fund ownership
Fund holdings as of
Funds holding1
Value of reported holdings$32,000
Funds buying / selling
Not available
Checking access…
Showing 1-20 of 83
1 / 5
Loading insider trades…
Loading Congress trades…
Loading activist filings…
Continue exploring
Similar stocks
347 holders · $19.6B
320 holders · $348.1B
288 holders · $546.5B
273 holders · $284.2B
269 holders · $133.7B
269 holders · $65.7B
260 holders · $36.2B
249 holders · $48.1B
242 holders · $48.9B
242 holders · $110.7B
Questions investors ask about RARX
Who owns RARX?
1 institutional investor held RARX on June 30, 2020, led by Daiwa Securities Group Inc. ($32,000).
How many hedge funds hold RARX?
1 institutional investor reported RARX in their 13F filings for the quarter ended June 30, 2020, $32,000 in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer